Fredun Pharmaceuticals (FREDUN) Share Price Hits Fresh 52-Week High on Market Cap Gain
- October 8, 2026
- Posted by: Kunal Singla
- Category: News
Fredun Pharmaceuticals Share Price opened higher and moved to a fresh 52-week high of Rs 1,605 before last trading at Rs 1,593, up 7.92% from the previous close, with market capitalisation at Rs 2,405.33 crore. According to latest Univest figures, the move is event-led because the stock has marked a one-year high while the latest Univest data also shows a clear valuation and return-ratio profile that investors can compare with healthcare peers. Fredun Pharmaceuticals Share Price is therefore drawing interest as a price event plus fundamental context story, not as a simple intraday spike. In Univest coverage, the key question is how the current price, valuation multiples and sector benchmark fit together. Fredun Pharmaceuticals Share Price, Fredun Pharmaceuticals Share Price Today and Fredun Pharmaceuticals Stock News are all being discussed around the same fresh 52-week peak.
Fredun Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,593 |
| Previous Close | Rs 1,476.05 |
| Today's Move | +Rs 116.95 (+7.92%) |
| Open | Rs 1,489.55 |
| High | Rs 1,605 |
| Low | Rs 1,463.45 |
| Market Capitalisation | Rs 2,405.33 crore |
Fredun Pharmaceuticals Ltd. (FREDUN) traded at Rs 1,593 versus the previous close of Rs 1,476.05, a rise of 7.92%. The stock opened at Rs 1,489.55, reached a high of Rs 1,605 and touched a low of Rs 1,463.45.
Fredun Pharmaceuticals Share Price is trading at Rs 1,593 after moving between Rs 1,463.45 and Rs 1,605 during the session. The stock was above its previous close of Rs 1,476.05 by Rs 116.95, which equals 7.92%. It opened at Rs 1,489.55 and touched the fresh 52-week high of Rs 1,605, making the day high identical to the yearly high. That makes Fredun Pharmaceuticals Share Price a clean 52-week high event rather than a broader end-of-day narrative. For readers tracking Fredun Pharmaceuticals Share Price Today, the important point is that the price stayed above the open and well inside the day’s range after hitting the peak.Fredun Pharmaceuticals Share Price now moves into valuation discussion, which is where Fredun Pharmaceuticals Share Price, Fredun Pharmaceuticals Share Price Today and Fredun Pharmaceuticals Fundamental Analysis become relevant together.
Why Fredun Pharmaceuticals Ltd. (FREDUN) May Be Moving Today
Fredun Pharmaceuticals Ltd. (FREDUN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,405.33 crore |
| P/E Ratio | 57.54x |
| P/B Ratio | 8.27x |
| ROE | 16.09% |
| ROCE | 21.34% |
| EPS | Rs 25.65 |
| Book Value Per Share | Rs 178.46 |
| Dividend Yield | 0.02% |
Fredun Pharmaceuticals Ltd. (FREDUN) fundamental metrics show P/E 57.54x, P/B 8.27x, ROE 16.09%, ROCE 21.34%. Taken on their own, these numbers offer context rather than a trading signal.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 57.54x |
| Benchmark Median P/E | 31.79x |
| Benchmark Average P/E | 48.42x |
| Benchmark P/E Range | 3.58x to 708.87x |
| Company P/B Ratio | 8.27x |
| Benchmark Median P/B | 2.96x |
| Company ROE | 16.09% |
| Benchmark Median ROE | 11.53% |
| Company ROCE | 21.34% |
| Benchmark Median ROCE | 13.32% |
| Company Market Capitalisation | Rs 2,405.33 crore |
| Benchmark Median Market Cap | Rs 828.13 crore |
Fredun Pharmaceuticals Ltd. (FREDUN) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Fredun Pharmaceuticals Ltd. (FREDUN) has a P/E ratio of 57.54x, which is above the benchmark median of 31.79x, a difference of +81%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Fredun Pharmaceuticals Ltd. (FREDUN) has a ROE of 16.09%, which is above the benchmark median of 11.53%, a difference of +39.55%. Fredun Pharmaceuticals Ltd. (FREDUN) has a ROCE of 21.34%, which is above the benchmark median of 13.32%, a difference of +60.21%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,404.27 | 148 | 0.36 | 1.56 | 3.21 |
| Venus Remedies Ltd. | VENUSREM | 2,377.59 | 19.96 | 3.38 | 16.79 | 21.88 |
| Sakar Healthcare Ltd. | SAKAR | 2,332.9 | 62.88 | 6.78 | 6.48 | 8.43 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,322.72 | 139.89 | 2.96 | 4.88 | 6.1 |
| Indoco Remedies Ltd. | INDOCO | 2,287.28 | 403.89 | 2.28 | -10.13 | 0.79 |
Fredun Pharmaceuticals Ltd. (FREDUN) has a P/E ratio of 57.54x compared with the displayed peer median of 139.89x. The comparison is relative and should not be read as a recommendation. Its ROE of 16.09% compares with a peer median of 4.88% across the companies shown in the table. ROCE stood at 21.34% versus the displayed peer median of 6.1%, providing a capital-efficiency comparison. Fredun Pharmaceuticals Ltd. (FREDUN) has a market capitalisation of Rs 2,405.33 crore. It is larger by market capitalisation than all 5 peers shown.
Why Investors Are Watching Fredun Pharmaceuticals
- Fredun Pharmaceuticals Share Price touched a fresh 52-week high of Rs 1,605 and last traded at Rs 1,593.
- The day change in Fredun Pharmaceuticals Share Price was Rs 116.95, which equals 7.92% over the previous close.
- Fredun Pharmaceuticals Share Price has a P/E of 57.54 and a P/B of 8.27.
- ROE for Fredun Pharmaceuticals Share Price is 16.09% and ROCE is 21.34%.
- Jun 2026 revenue for Fredun Pharmaceuticals is Rs 228.25 crore, while market capitalisation is Rs 2,405.33 crore.
About Fredun Pharmaceuticals
Fredun Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry.In Univest coverage, Fredun Pharmaceuticals Share Price is therefore tracked as a pharmaceuticals name with a stated business transition and a current market-cap scale of Rs 2,405.33 crore.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What is Fredun Pharmaceuticals Share Price today?
Ans. Fredun Pharmaceuticals Share Price was at Rs 1,593, up 7.92% from the previous close of Rs 1,476.05. The stock also touched Rs 1,605 during the day, which is its fresh 52-week high.
Did Fredun Pharmaceuticals Share Price hit a 52-week high?
Ans. Yes, Fredun Pharmaceuticals Share Price touched a fresh 52-week high of Rs 1,605. The current trade level was Rs 1,593, so the stock remained close to the day’s peak during trading.
What is the market capitalisation of Fredun Pharmaceuticals?
Ans. Fredun Pharmaceuticals has a market capitalisation of Rs 2,405.33 crore. In the latest Univest figures, that places Fredun Pharmaceuticals Share Price above the industry median market-cap level in the same sector group.
How does Fredun Pharmaceuticals Share Price compare on valuation?
Ans. Fredun Pharmaceuticals Share Price trades at a P/E of 57.54 and a P/B of 8.27. Both are above the sector medians of 31.79 and 2.96, indicating a richer valuation than the benchmark.
What do ROE and ROCE show for Fredun Pharmaceuticals?
Ans. Fredun Pharmaceuticals reports ROE of 16.09% and ROCE of 21.34%. Both are above the sector medians, which gives Fredun Pharmaceuticals Share Price stronger return-ratio context than many listed industry peers.
What is the latest revenue figure for Fredun Pharmaceuticals?
Ans. Revenue for Jun 2026 is Rs 228.25 crore. That figure gives Fredun Pharmaceuticals Share Price operating context alongside the valuation ratios, market capitalisation and return ratios observed in the latest Univest figures.
How does Fredun Pharmaceuticals compare with peers?
Ans. Compared with peers such as Venus Remedies, Sakar Healthcare and Indoco Remedies, Fredun Pharmaceuticals Share Price shows stronger return ratios than several names, while its valuation is higher than some and lower than others in the group.
What is the book value and EPS for Fredun Pharmaceuticals?
Ans. EPS is Rs 25.65 and book value is Rs 178.46 per share. These numbers help frame Fredun Pharmaceuticals Share Price by showing earnings per share and the accounting net worth behind each share.
Track Fredun Pharmaceuticals Share Price on Univest
Use Fredun Pharmaceuticals Ltd. (FREDUN) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Fredun Pharmaceuticals Share Price on Univest to follow live price, 52-week levels, valuation ratios, return metrics, market capitalisation and the latest company context in one place. Fredun Pharmaceuticals Share Price Today can be monitored alongside Fredun Pharmaceuticals Stock Analysis and Fredun Pharmaceuticals Fundamental Analysis without leaving the platform.
